Lipid-Activated Nuclear Receptors and Sepsis

Author(s): Thais Martins de Lima-Salgado, Luiz Monteiro Cruz, Heraldo Possolo Souza

Journal Name: Endocrine, Metabolic & Immune Disorders - Drug Targets
Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders

Volume 10 , Issue 3 , 2010

Become EABM
Become Reviewer
Call for Editor


It is now clear that several members of the nuclear receptor superfamily are co-expressed by macrophages, lymphocytes and other cell types that are involved in the regulation of inflammatory and immune responses. Peroxisome proliferator-activated receptors (PPAR) and nuclear liver X receptors (LXR) are members of this family known to be activated by lipid derived endogenous ligands (such as fatty acids, eicosanoids and cholesterol) and pharmacological ones. Here we review the biology of these nuclear receptors and highlight recent work that show that their activation can ameliorate inflammatory conditions, especially due to their effect on macrophage functions. The data discussed herein show the potential beneficial effect of targeting these nuclear receptors in order to improve the outcome of septic patients.

Keywords: Inflammation, fatty acids, liver-x receptors, nuclear receptor, peroxisome proliferator-activated receptors, sepsis

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2010
Page: [258 - 265]
Pages: 8
DOI: 10.2174/187153010791936937
Price: $65

Article Metrics

PDF: 11